Restoring the man-microbes symbiotic relationship…….


MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up, created at the end of 2014, to treat serious diseases linked to imbalances in the intestinal microbiome. It has developed the first treatment solution based on autologous microbiotherapy. MaaT Pharma envisages a first therapeutic application for patients suffering from leukaemia and bone & joint infections, whose major treatment contributes to dysbiosis. Funded jointly by a team which brings together world-class medical-scientific and entrepreneurial skills, MaaT Pharma has the ambition of becoming a leader in microbiome protection and the treatment of dysbiosis.

One of the top rated French health TV shows

“Le Magazine de la Santé”, one of the top rated French health TV shows, explained MaaT Pharma's Fecal Microbiota Transfer dedicated to patients with acute myeloid leukemia and to the ones treated with massive antibiotics therapies! Dive into our daily life, it’s right...

The Microbiome Edition

 EDITO As we turn the page of 2016, we, at MaaT Pharma - a microbiome–based biotech revolutionizing and shaping individualized therapies to treat serious diseases linked to dysbioses (gut microbiota imbalances)-, want to wish you a happy and healthy new year!  2016...

Latest Tweets